ST. LOUIS (AP) — Prescription drug spending growth slowed last year, as the introduction of generic medicines helped balance price increases, according to pharmacy benefits manager Express Scripts Inc.

The St. Louis company said that spending increased 2.7 percent in 2011, the lowest growth recorded in 18 years of measuring the statistic. Express Scripts did not release a total dollar figure for the spending.

Top-selling drugs like Pfizer Inc.'s cholesterol fighter Lipitor and Eli Lilly and Co.'s antipsychotic Zyprexa lost U.S. patent protection last year, exposing the treatments to competition from cheaper generic medication.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.